Overexpression of ecto-5′-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix

Cancer Biology and Therapy

Volumn 6, Issue 3, 2007, Pages 426-431

  Zhou, Ping ^a   Zhi, Xiuling ^a   Zhou, Tingting ^a   Chen, Sifeng ^a   Li, Xiaobo ^a   Wang, Li ^a   Yin, Lianhua ^a   Shao, Zhimin ^a   Ou, Zhouluo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adenosine; Adenosine receptor; Adhesion; Breast cancer; CD73; Invasion; Migration

Indexed keywords

5' NUCLEOTIDASE; CARBENE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 34548255860     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.3.3762     Document Type: Article

References (34)

1. Kallioniemi A. Molecular signatures of breast cancer-predicting the future. N Engl J Med 2002; 347:2067-8.
2. Vogel VG. Breast cancer prevention: A review of current evidence. CA Cancer J Clin 2000; 50:156-70.
3. Henttinen T, Jalkanen S, Yegutkin GG. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5′-nucleotidase/CD73-dependent mechanism. J Biol Chem 2003; 278:24888-95.
4. Resta R, Thompson LF. T cell signalling through CD73. Cell Signal 1997; 9:131-9.
5. Ludwig HC, Rausch S, Schallock K, Markakis E. Expression of CD 73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res 1999; 19:1747-52.
6. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 2000; 87:161-73.
7. Kruger KH, Thompson LF, Kaufmann M, Moller P. Expression of ecto-5′-nucleotidase (CD73) in normal mammary gland and in breast carcinoma. Br J Cancer 1991; 63:114-8.
8. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, Sager R. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 2000; 60:2232-8.
9. Spychala J, Lazarowski E, Ostapkowicz A, Ayscue LH, Jin A, Mitchell BS. Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer. Clin Cancer Res 2004; 10:708-17.
10. Bonitati AE, Agarwal KC, Rounds S. A simple assay for ecto-5′-nucleotidase using intact pulmonary artery endothelial cells: Effect of endotoxin-induced cell injury. Biochem Pharmacol 1993; 46:1467-73.
11. Zhang M, Zhang X, Bai CX, Chen J, Wei MQ. Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells. Acta Pharmacol Sin 2004; 25:61-7.
12. Kamath L, Meydani A, Foss F, Kuliopulos A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 2001; 61:5933-40.
13. Zhou TT. Crucial role for ecto-5′-nucleotidase (CD73) in invasion and migration of human breast cancer cell lines. Chinese Journal of Pathophysiology 2006; 22:360-4.
14. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001; 61:5168-78.
15. Bartsch JE, Staren ED, Appert HE. Adhesion and migration of extracellular matrix-stimulated breast cancer. J Surg Res 2003; 110:287-94.
16. Navarro JM, Olmo N, Turnay J, Lopez-Conejo MT, Lizarbe MA. Ecto-5′-nucleotidase from a human colon adenocarcinoma cell line: Correlation between enzyme activity and levels in intact cells. Mol Cell Biochem 1998; 187:121-31.
17. Arvilommi AM, Salmi M, Airas L, Kalimo K, Jalkanen S. CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. Eur J Immunol 1997; 27:248-54.
18. Bianchi V, Spychala J. Mammalian 5′-nucleotidases. J Biol Chem 2003; 278:46195-8.
19. MacLellan DL, Steen H, Adam RM, Garlick M, Zurakowski D, Gygi SP, Freeman MR, Solomon KR. A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells. Proteomics 2005; 5:4733-42.
20. Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 1990; 85:1150-7.
21. Adair TH. Growth regulation of the vascular system: An emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 2005; 289:R283-R96.
22. Woodhouse EC, Amanatullah DF, Schetz JA, Liotta LA, Stracke ML, Clair T. Adenosine receptor mediates motility in human melanoma cells. Biochem Biophys Res Commun 1998; 246:888-94.
23. Li S, Guan JL, Chien S. Biochemistry and biomechanics of cell motility. Annu Rev Biomed Eng 2005; 7:105-50.
24. Mehul B, Doyennette-Moyne MA, Aubery M, Codogno P, Mannherz HG. Enzymatic activity and in vivo distribution of 5′-nucleotidase, an extracellular matrix binding glycoprotein, during the development of chicken striated muscle. Exp Cell Res 1992; 203:62-71.
25. Mehul B, Aubery M, Mannherz HG, Codogno P. Dual mechanism of laminin modulation of ecto-5′-nucleotidase activity. J Cell Biochem 1993; 52:266-74.
26. Ioachim E, Kamina S, Kontostolis M, Agnantis NJ. Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer. Virchows Arch 1997; 431:311-6.
27. Gorczyca W, Holm R, Nesland JM. Laminin production and fibronectin immunoreactivity in breast carcinomas. Anticancer Res 1993; 13:851-8.
28. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233:467-70.
29. Ohnishi T, Arita N, Hiraga S, Taki T, Izumoto S, Fukushima Y, Hayakawa T. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 1997; 15:538-46.
30. Nielsen M, Christensen L, Albrechtsen R. The basement membrane component laminin in breast carcinomas and axillary lymph node metastases. Acta Pathol Microbiol Immunol Scand [A] 1983; 91:257-64.
31. Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 1981; 41:5076-81.
32. Quintela I, Corte MD, Allende MT, Vazquez J, Rodriguez JC, Bongera M, Lamelas M, Gonzalez LO, Vega A, Garcia-Muniz JL, Astudillo A, Vizoso F. Expression and prognostic value of EGFR in invasive breast cancer. Oncol Rep 2005; 14:1655-63.
33. Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: From traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2006; 95:211-8.
34. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 2001; 158:639-46.